menu
    • menu

    Company profile for Vicinitas Therapeutics

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Willow Birch Pharma delivers trusted, high-quality APIs nationwide with unmatched service, compliance, and competitive value.

    Virtual Booth

    Contact Supplier

    AMI Lifesciences is Driven by Chemistry. Powered by People.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    The vision of Vicinitas Therapeutics is to become the leading company developing next-generation medicines that impact patient lives. Our vision is to use our proprietary Deubiquitinase Targeting Chimera (DUBTAC) platform to restore the levels of aberrantly degraded proteins that cause disease to confer therapeutic benefit.Vicinitas Therapeutics will focus on developing differentiated disease therapies based on our targeted pr...
    The vision of Vicinitas Therapeutics is to become the leading company developing next-generation medicines that impact patient lives. Our vision is to use our proprietary Deubiquitinase Targeting Chimera (DUBTAC) platform to restore the levels of aberrantly degraded proteins that cause disease to confer therapeutic benefit.Vicinitas Therapeutics will focus on developing differentiated disease therapies based on our targeted protein stabilization platform for stabilizing the levels of aberrantly ubiquitinated and degraded proteins that drive disease pathogenesis.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Vicinitas TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    442 Littlefield Ave. South San Francisco, CA 94080
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://vicinitastx.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Vicinitas Therapeutics Appoints Adam Hughes as Chief Scientific Officer
    Vicinitas Therapeutics Appoints Adam Hughes as Chief Scientific Officer

    02 May 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/05/02/2874131/0/en/Vicinitas-Therapeutics-Appoints-Adam-Hughes-as-Chief-Scientific-Officer.html

    GLOBENEWSWIRE
    02 May 2024
    Share Share
    Vicinitas Therapeutics Appoints Christian Hofmann, Ph.D., as CEO
    Vicinitas Therapeutics Appoints Christian Hofmann, Ph.D., as CEO

    09 May 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20230508005572/en

    BUSINESSWIRE
    09 May 2023
    Share Share

    Drugs in Development

    read-more
    read-more
    • Deals
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Vicinitas Therapeutics Launches With $65 Million in Series A Financing to Advance Precision Medicines to Stabilize Key Proteins to Treat Disease

    Details:

    The DUBTAC platform was developed to therapeutically target these degraded proteins by removing ubiquitin chains, from specific proteins to stop their degradation and stabilize their levels for therapeutic benefit.


    Lead Product(s): Undisclosed,Inapplicable

    Therapeutic Area: Oncology Brand Name: Undisclosed

    Study Phase: Discovery PlatformProduct Type: Undisclosed

    Sponsor: 16z

    Deal Size: $65.0 million Upfront Cash: Undisclosed

    Deal Type: Series A Financing July 28, 2022

    blank

    01

    Vicinitas Therapeutics

    U.S.A
    arrow
    Global ChemShow
    Not Confirmed

    Vicinitas Therapeutics

    U.S.A
    arrow
    Global ChemShow
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Lead Product(s) : Undisclosed,Inapplicable

    Therapeutic Area : Oncology

    Highest Development Status : Discovery Platform

    Partner/Sponsor/Collaborator : 16z

    Deal Size : $65.0 million

    Deal Type : Series A Financing

    DEALS_DEV arrow-down

    Vicinitas Therapeutics Launches With $65 Million in Series A Financing to Advance Precision Medici...

    Details : The DUBTAC platform was developed to therapeutically target these degraded proteins by removing ubiquitin chains, from specific proteins to stop their degradation and stabilize their levels for therapeutic benefit.

    Product Name : Undisclosed

    Product Type : Undisclosed

    Upfront Cash : Undisclosed

    July 28, 2022

    blank

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    Virtual Booth

    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search